EDITORIAL
Live-Attenuated Vaccines in Solid Organ Transplant: Is It Time for a Practice Change?
First published: 19 November 2024
Funding: The authors received no specific funding for this work.
No abstract is available for this article.
Conflicts of Interest
P.-P.P.-R. has been a co-investigator on an investigator-led project funded by Pfizer that is unrelated to this current work. J.U. reports grants and personal fees from DBV Technologies, ALK-Abelló, personal fees from Astra Zeneca, Genentech, Bausch Health, Pfizer, Viatris, Pharming Group N.V, grants from Sanofi/Regeneron, CIHR, research support from Novartis, board of director at Canadian Society of Allergy and Clinical Immunology, Healthcare Advisory Board Food Allergy Canada, all unrelated to this current work.
Open Research
Data Availability Statement
Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
